Newsroom
Sorted by: Latest
-
Star Therapeutics Announces $200 Million Private Financing to Advance Pipeline of Best-in-Disease Therapies
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Star Therapeutics, a biotechnology company focused on the discovery and development of life-changing therapies for diseases with significant unmet need, today announced a $200 million private financing. The financing follows the July 2026 acquisition of Star subsidiary Vega Therapeutics and was co-led by OrbiMed and Janus Henderson Investors, with participation from Agent Capital, Catalio Capital Management, Cormorant Asset Management, New Leaf Vent...
-
Foundation Medicine’s FoundationOne®MRD Named a 2026 Top Innovation Winner by The Scientist
BOSTON--(BUSINESS WIRE)--Foundation Medicine's molecular residual disease (MRD) assay, FoundationOne®MRD, has been named a 2026 Top Innovation by The Scientist....
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust IPOX Europe Equity Opportunities UCITS ETF 22.10.2026 IPXE.IM IE00BFD26097 50,002.00 EUR 1,195,577.64 23.911 ...
-
American Express Reports Third-Quarter 2026 Financial Results
NEW YORK--(BUSINESS WIRE)--American Express Company (NYSE: AXP) today reported its third-quarter 2026 financial results. The earnings release and supplemental financial data are available on the company’s Investor Relations website at http://ir.americanexpress.com. An investor conference call will be held at 8:30 a.m. (ET) today to discuss the company’s third-quarter 2026 results. Live audio and presentation slides for the investor conference call will be available to the general public on the...
-
ACCO Brands Corporation Declares Quarterly Dividend
LAKE ZURICH, Ill.--(BUSINESS WIRE)--ACCO Brands Corporation Declares Quarterly Dividend...
-
Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3 easyJet plc
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Cloud Computing UCITS ETF 22.10.2026 CPQ IE00BFD2H405 6,200,002.00 USD 427,961,139.56 69.026 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones Internet UCITS ETF 22.10.2026 FDNU IE00BG0SSC32 1,250,002.00 USD 48,523,533.85 38.819 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Cybersecurity UCITS ETF 22.10.2026 NQCYBREN IE00BF16M727 30,489,755.00 USD 1,956,652,229.56 64.174 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 22.10.2026 FBTU.LN IE00BL0L0H60 550,002.00 USD 18,351,075.47 33.365 ...